Join leaders at the forefront of gene therapy development, offering insights on navigating the latest advancements and challenges in gene therapy production.
3rd Annual Gene Therapy Development Congress Gain an end-to-end outlook on the entire journey of gene therapy development, with 5 tracks exploring the discovery, clinical trial, manufacturing, and commercialisation of gene therapies. Tackle the latest challenges in our interactive sessions featuring panel discussions and roundtables, addressing pressing issues such as vector design, gene engineering, preparing for regulatory changes, and more Benefit from real-world case studies presented by industry experts, including insights into how to navigate regulatory submission, as well as operationalising clinical trials Acquire practical solutions to overcome obstacles in the development and production of gene therapies, with opportunities to meet with and hear from vendor companies
What to Expect
250 leading pharma, biotech, & academic delegates
15 hours of presentations, discussions & interactive content
7 hours of networking breaks, including speed networking & refreshments
80 hours of pre-arranged 1-2-1 meetings, facilitating business growth
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences Engaging Thought Leadership
Over 45 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts Global Technological Showcase
An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field. Networking Emphasis
Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections Innovative Poster Displays
Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions